Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.74

-0.67

-0.61

-0.54

Details

Expected EPS

-0.737378

Actual EPS

-0.71

Surprise EPS

0.03

Surprise Percent

+3.71%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.71 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.